Clinical Trial Update: A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of oral valganciclovir (Valcyte) in pediatric kidney transplant recipients with Cytomegalovirus infections; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation, Cytomegalovirus Infections | Phase 4 | Status: COMPLETED | Results posted: 2014-04-28